Neurology Minute

Latest Episodes:

CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 3 Nov 18, 2024

Show notes

In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss how to differentiate between CAA-RI and PACNS.

Show reference: https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548

The Placebo Effect Nov 15, 2024

Show notes

Dr. Gregg Day and Dr. Kathryn T. Hall discuss the complexities of the placebo effect, its variability among patients, and the genetic factors that influence responses to placebo treatments.

CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 2 Nov 14, 2024

Show notes

In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss the underlying pathophysiology and how to diagnose primary angiitis of the CNS in clinical practice.

Show reference: https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548

CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 1 Nov 13, 2024

Show notes

In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Ahmad Nehme discuss how cerebral amyloid angiopathy and CAA-RI present in clinical practice and how to make a diagnosis.

Show reference:

https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209548

Lab Minute - Vitamin D Nov 12, 2024

Show notes

Dr. Stacey Clardy discusses vitamin D in this lab minute.

Could Reducing Environmental Toxins Help Mitigate the Risk for Parkinson's Disease? Where the Evidence Is Leading Nov 11, 2024

Show notes

Dr. Halley Alexander discusses the Neurology Today article, "Could Reducing Environmental Toxins Help Mitigate the Risk for Parkinson's Disease? Where the Evidence Is Leading" by Gina Shaw, available in the November 7th issue of Neurology Today or at neurologytoday.com.

Show reference:

https://journals.lww.com/neurotodayonline/pages/articleviewer.aspx?year=2024&issue=11070&article=00001&type=Fulltext

Genetic Leukodystrophies Mimicking CNS Inflammation - Part 3 Nov 08, 2024

Show notes

In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Jennifer L. Orthmann Murphy highlight important indicators for when to suspect hereditary spastic paraplegia, as well as guidelines for testing and interpreting results.

Show references: https://www.neurology.org/doi/10.1212/NXG.0000000000200192 https://cshperspectives.cshlp.org/content/early/2024/08/10/cshperspect.a041457

Genetic Leukodystrophies Mimicking CNS Inflammation - Part 2 Nov 07, 2024

Show notes

In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Jennifer L. Orthmann Murphy discuss practical approaches to genetic adrenoleukodystrophy.

Show references: https://www.neurology.org/doi/10.1212/NXG.0000000000200192

Genetic Leukodystrophies Mimicking CNS Inflammation - Part 1 Nov 06, 2024

Show notes

In the first part of this three-part series, Dr. Justin Abbatemarco and Dr. Jennifer L. Orthmann Murphy discuss red flag symptoms that suggest the need for genetic testing in patients with white matter disease.

Show references:

https://www.neurology.org/doi/10.1212/NXG.0000000000200192

https://cshperspectives.cshlp.org/content/early/2024/08/10/cshperspect.a041457

Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Nov 05, 2024

Show notes

Dr. Rae Bacharach discusses the Neurology Today article, "Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease," by Gina Shaw, available in the latest issue of Neurology Today or at neurologytoday.com.

Show reference:

https://journals.lww.com/neurotodayonline/pages/default.aspx

https://jamanetwork.com/journals/jamaneurology/article-abstract/2822964

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected